Georgios Papachristou MD
  • Georgios Papachristou, MD

    Dr. Georgios Papachristou is an advanced endoscopist with special interest in novel therapies for pancreatobiliary disorders using ERPC/EUS. Dr. Papachristou’s research involves pancreatitis and pancreatic cancer. The Severity of Acute Pancreatitis Study (SAPS-1), which focuses on the genetic basis, immulonology and immune therapy of acute pancreatitis, is managed primarily by Dr. Papachristou.

Georgios Papachristou, MD

Dr. Georgios Papachristou is an advanced endoscopist with special interest in novel therapies for pancreatobiliary disorders using ERPC/EUS. Dr. Papachristou’s research involves pancreatitis and pancreatic cancer. The Severity of Acute Pancreatitis Study (SAPS-1), which focuses on the genetic basis, immulonology and immune therapy of acute pancreatitis, is managed primarily by Dr. Papachristou.

Profile:

Dr. Georgios Papachristou is an advanced endoscopist with special interest in novel therapies for pancreatobiliary disorders using ERPC/EUS. Dr. Papachristou’s research involves pancreatitis and pancreatic cancer. The Severity of Acute Pancreatitis Study (SAPS-1), which focuses on the genetic basis, immulonology and immune therapy of acute pancreatitis, is managed primarily by Dr. Papachristou.